Allogene Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Allogene Therapeutics, Inc. has filed 570 SEC EDGAR filings since 19 Apr 2018

SEC filing history

Showing 276-300 of 570 matching filings.

Per page
25
Current page
12
SC 13G File 005-90685

SC 13G filing

Filing date
03 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jan 2023
Reporting date
20 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Jan 2023
Reporting date
17 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
09 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Dec 2022
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-268117

S-3ASR

Filing date
02 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Oct 2022
Reporting date
07 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Oct 2022
Reporting date
03 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Aug 2022
Reporting date
11 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Aug 2022
Reporting date
11 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Aug 2022
Reporting date
02 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-I/A File 005-90685

SC TO-I/A

Filing date
20 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jul 2022
Reporting date
08 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
12 Jul 2022
Reporting date
08 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-I/A File 005-90685

SC TO-I/A

Filing date
12 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jul 2022
Reporting date
05 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .